bisantrene has been researched along with alprostadil in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baudin, B; Drouet, L; Scrobohaci, ML | 1 |
1 other study(ies) available for bisantrene and alprostadil
| Article | Year |
|---|---|
[Hemostasis tests as markers of hepatic and endothelial toxicity in chemotherapy].
Topics: Alprostadil; Anthracenes; Antineoplastic Agents; Asparaginase; Bone Marrow Transplantation; Cyclosporins; Endothelium, Vascular; Factor VII; Hemostatic Techniques; Humans; Liver; Protein C | 1988 |